Armistice Capital, Llc Avalo Therapeutics, Inc. (AVTX) insider trading activity

Armistice Capital, LLC is > 10% Shareholder of Avalo Therapeutics, Inc.. Currently has a direct ownership of 39.1 Million shares of AVTX, which is worth approximately $378 Million. The most recent transaction as insider was on Dec 04, 2018, when has been sold 2,200 shares (Common Stock) at a price of $3.4 per share, resulting in proceeds of $7,480. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.1M

0% 3M change

0% 12M change

Total Value Held $378 Million

ARMISTICE CAPITAL, LLC Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 04 2018	BUY Open market or private purchase	$7,480 $3.4 p/Share	2,200 Added 0.01%	18,003,600 Common Stock
Dec 03 2018	BUY Open market or private purchase	$68,232 $3.5 p/Share	19,495 Added 0.11%	18,001,400 Common Stock
Nov 30 2018	BUY Open market or private purchase	$14,357 $3.5 p/Share	4,102 Added 0.02%	17,981,905 Common Stock
Nov 29 2018	BUY Open market or private purchase	$61,954 $3.48 p/Share	17,803 Added 0.1%	17,977,803 Common Stock
Nov 28 2018	BUY Open market or private purchase	$117,378 $3.52 p/Share	33,346 Added 0.19%	17,960,000 Common Stock
Nov 27 2018	BUY Open market or private purchase	$93,556 $3.51 p/Share	26,654 Added 0.15%	17,926,654 Common Stock
Nov 26 2018	BUY Open market or private purchase	$125,300 $3.58 p/Share	35,000 Added 0.2%	17,900,000 Common Stock
Nov 23 2018	BUY Open market or private purchase	$18,200 $3.64 p/Share	5,000 Added 0.03%	17,865,000 Common Stock
Nov 21 2018	BUY Open market or private purchase	$35,800 $3.58 p/Share	10,000 Added 0.06%	17,860,000 Common Stock
Nov 20 2018	BUY Open market or private purchase	$50,540 $3.61 p/Share	14,000 Added 0.08%	17,850,000 Common Stock
Nov 19 2018	BUY Open market or private purchase	$84,728 $3.56 p/Share	23,800 Added 0.13%	17,836,000 Common Stock
Nov 16 2018	BUY Open market or private purchase	$42,036 $3.72 p/Share	11,300 Added 0.06%	17,812,200 Common Stock
Nov 15 2018	BUY Open market or private purchase	$42,516 $3.79 p/Share	11,218 Added 0.06%	17,800,900 Common Stock
Nov 14 2018	BUY Open market or private purchase	$18,322 $3.81 p/Share	4,809 Added 0.03%	17,789,682 Common Stock
Nov 13 2018	BUY Open market or private purchase	$59,619 $3.9 p/Share	15,287 Added 0.09%	17,784,873 Common Stock
Oct 31 2018	BUY Open market or private purchase	$17,931 $3.91 p/Share	4,586 Added 0.03%	17,769,586 Common Stock
Oct 30 2018	BUY Open market or private purchase	$5,558 $3.97 p/Share	1,400 Added 0.01%	17,765,000 Common Stock
Oct 29 2018	BUY Open market or private purchase	$131,170 $3.94 p/Share	33,292 Added 0.19%	17,763,600 Common Stock
Oct 26 2018	BUY Open market or private purchase	$219,683 $3.93 p/Share	55,899 Added 0.31%	17,730,308 Common Stock
Oct 25 2018	BUY Open market or private purchase	$74,250 $3.99 p/Share	18,609 Added 0.11%	17,674,409 Common Stock
Oct 24 2018	BUY Open market or private purchase	$346,094 $4.13 p/Share	83,800 Added 0.47%	17,655,800 Common Stock
Oct 23 2018	BUY Open market or private purchase	$92,400 $4.2 p/Share	22,000 Added 0.13%	17,572,000 Common Stock
Oct 22 2018	BUY Open market or private purchase	$86,200 $4.31 p/Share	20,000 Added 0.11%	17,550,000 Common Stock
Oct 09 2018	BUY Open market or private purchase	$28,535 $4.39 p/Share	6,500 Added 0.04%	17,530,000 Common Stock
Oct 08 2018	BUY Open market or private purchase	$84,816 $4.33 p/Share	19,588 Added 0.11%	17,523,500 Common Stock

Also insider at

BBI

Brickell Biotech, Inc. Healthcare

> 10% Shareholder

ALIM

ALIMERA SCIENCES INC Healthcare

> 10% Shareholder

KPRX

KIORA PHARMACEUTICALS INC Healthcare

> 10% Shareholder

SAVA

CASSAVA SCIENCES INC Healthcare

> 10% Shareholder

DFRG

Del Frisco's Restaurant Group, Inc.

> 10% Shareholder

VLRX

Valeritas Holdings Inc.

> 10% Shareholder

BPTH

BIO-PATH HOLDINGS INC Healthcare

> 10% Shareholder

AYTU

AYTU BIOPHARMA, INC Healthcare

Director

ACHV

ACHIEVE LIFE SCIENCES, INC. Healthcare

> 10% Shareholder

AMAG

AMAG PHARMACEUTICALS, INC.

> 10% Shareholder

RSLS

ReShape Weightloss Inc.

> 10% Shareholder

INNV

INNOVUS PHARMACEUTICALS, INC.

> 10% Shareholder

ONTX

Onconova Therapeutics, Inc. Healthcare

> 10% Shareholder

VXRT

Vaxart, Inc. Healthcare

Director

TTPH

TETRAPHASE PHARMACEUTICALS INC

Director

TENX

TENAX THERAPEUTICS, INC. Healthcare

Director

CYTH

Cyclo Therapeutics, Inc. Healthcare

> 10% Shareholder

RSLS

ReShape Lifesciences Inc. Healthcare

> 10% Shareholder

ACL